These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8269181)

  • 21. Neurohumoral effects of digoxin: a target for further investigation.
    Gheorghiade M
    Cardiologia; 1996 Oct; 41(10):967-72. PubMed ID: 8940784
    [No Abstract]   [Full Text] [Related]  

  • 22. [Digoxin in chronic heart failure].
    Motz W
    Dtsch Med Wochenschr; 1993 Dec; 118(48):1786. PubMed ID: 8253039
    [No Abstract]   [Full Text] [Related]  

  • 23. Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).
    Massie BM; Berk MR; Brozena SC; Elkayam U; Plehn JF; Kukin ML; Packer M; Murphy BE; Neuberg GW; Steingart RM
    Circulation; 1993 Aug; 88(2):492-501. PubMed ID: 8339411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rationalizing the heart failure trials: from theory to practice.
    Struthers AD
    Eur Heart J; 1997 Nov; 18 Suppl E():E5-8. PubMed ID: 9402465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Superiority of "triple" drug therapy in heart failure: insights from the PROVED and RADIANCE trials. Prospective Randomized Study of Ventricular Function and Efficacy of Digoxin. Randomized Assessment of Digoxin and Inhibitors of Angiotensin-Converting Enzyme.
    Young JB; Gheorghiade M; Uretsky BF; Patterson JH; Adams KF
    J Am Coll Cardiol; 1998 Sep; 32(3):686-92. PubMed ID: 9741512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drugs for chronic heart failure.
    Med Lett Drugs Ther; 1999 Jan; 41(1045):12-4. PubMed ID: 9949763
    [No Abstract]   [Full Text] [Related]  

  • 27. Heart failure.
    McKelvie R
    Clin Evid; 2002 Dec; (8):60-81. PubMed ID: 12603873
    [No Abstract]   [Full Text] [Related]  

  • 28. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.
    Packer M; Gheorghiade M; Young JB; Costantini PJ; Adams KF; Cody RJ; Smith LK; Van Voorhees L; Gourley LA; Jolly MK
    N Engl J Med; 1993 Jul; 329(1):1-7. PubMed ID: 8505940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intractable heart failure despite angiotensin-converting enzyme inhibitors, digoxin, and diuretics: long-term effectiveness of add-on therapy with pimobendan.
    Hagemeijer F
    Am Heart J; 1991 Aug; 122(2):517-22. PubMed ID: 1858635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology.
    Gambassi G; Lapane KL; Sgadari A; Carbonin P; Gatsonis C; Lipsitz LA; Mor V; Bernabei R
    Arch Intern Med; 2000 Jan; 160(1):53-60. PubMed ID: 10632305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Heart failure - up to date].
    Müller-Edenborn B; Eriksson U
    Praxis (Bern 1994); 2013 Aug; 102(17):1053-60. PubMed ID: 23965718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination drug therapy in chronic heart failure: is treatment part of the problem in heart failure?
    Cleland JG
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():297-303. PubMed ID: 9211024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Was it digoxin toxicity?...very likely.
    Ruelaz RA; Rahimtoola SH
    J Card Fail; 2005 Mar; 11(2):87-90. PubMed ID: 15732026
    [No Abstract]   [Full Text] [Related]  

  • 34. Should all patients with congestive heart failure and dilated cardiomyopathy be treated with vasodilators?
    Massie BM
    Cardiovasc Clin; 1990; 21(1):251-62; discussion 263-4. PubMed ID: 2199051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasodilator therapy in heart failure.
    Kubo SH
    J Heart Lung Transplant; 1994; 13(4):S122-5. PubMed ID: 7947868
    [No Abstract]   [Full Text] [Related]  

  • 36. [Heart failure, summary and perspectives].
    Just H
    Z Kardiol; 1992; 81 Suppl 4():105-8. PubMed ID: 1290286
    [No Abstract]   [Full Text] [Related]  

  • 37. Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study.
    Majumdar SR; McAlister FA; Cree M; Chang WC; Packer M; Armstrong PW;
    Clin Ther; 2004 May; 26(5):694-703. PubMed ID: 15220013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Failure of many new heart-failure drugs: the need for vasoconstrictor rather than vasodilator agents?
    Cleland JG
    Br J Hosp Med; 1994 Sep 7-20; 52(5):193, 195-6. PubMed ID: 7820314
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of heart failure: what--when--how?].
    Blömer H
    Verh Dtsch Ges Inn Med; 1990; 96():157-67. PubMed ID: 2092435
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group.
    Cohn JN; Ziesche S; Smith R; Anand I; Dunkman WB; Loeb H; Cintron G; Boden W; Baruch L; Rochin P; Loss L
    Circulation; 1997 Aug; 96(3):856-63. PubMed ID: 9264493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.